Rite Aid and McKesson Agree to Key Terms for Pharmaceutical Purchasing and Distribution
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
JPMorgan Reiterates Neutral on Rite Aid (RAD) Following 3Q Report
December 21, 2018 7:25 AM ESTJPMorgan analyst, Lisa Gill, reiterated a Neutral rating on Rite-Aid (NYSE: RAD) following the company's 3Q earnings report. Adjusted EBITDA was $13M above forecasts, with upside driven mainly on the gross profit line. Adjusted EPS of +$0.01 compared to estimates of -$0.01.
In the retail... More
